Toxicity and Morbidity After Isolated Lower Limb Perfusion for Melanoma
Author Information
Author(s): Pace Marcello, Gattai Riccardo, Matteini Maria, Mascitelli Erminia Macera, Bechi Paolo
Primary Institution: University of Florence
Hypothesis
The study aims to assess the regional and systemic toxicity and complications in 242 chemo-hyperthermal treatments for lower limb melanoma.
Conclusion
The study suggests that technical improvements have reduced the occurrence and severity of side effects and complications in lower limb perfusion treatments.
Supporting Evidence
- Limb toxicity was very low in G-A and G-B groups.
- In G-C, 37% of patients experienced grade III toxicity.
- No grade IV toxicity was registered across all groups.
- Postoperative complications were acceptable with a mortality rate of 1.2%.
Takeaway
Doctors used a special treatment to help people with melanoma in their legs, and they found that it was mostly safe and didn't cause many problems.
Methodology
The study analyzed 242 isolated limb perfusions performed on patients with lower limb melanoma, assessing toxicity and complications over a 30-day postoperative period.
Potential Biases
Potential bias due to the retrospective design and the variability in treatment protocols across different groups.
Limitations
The study is retrospective and may have selection bias due to the nature of the patient selection.
Participant Demographics
213 patients (168 women and 74 men) with a mean age of 56.6 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website